2023-09-11 08:49:41 ET
More on Bausch + Lomb
- Seeking Alpha’s Quant Rating on Bausch + Lomb
- Historical earnings data for Bausch + Lomb
- Financial information for Bausch + Lomb
- Bausch + Lomb: Growth Should Accelerate As Supply Issues Ease
- Bausch + Lomb Corporation ( BLCO ) Q2 2023 Earnings Call Transcript
- Bausch + Lomb: $2.5bn M&A Deal Shows It Hasn't Learned From Parent's Mistakes
- Bausch + Lomb creates 2 new roles as part of changes to executive leadership team
- Bausch + Lomb buys Blink eye drops from Johnson & Johnson
- Bausch + Lomb to buy dry-eye therapy from Novartis for over $1B
For further details see:
Bausch Health to raise debt to finance Novartis deal